戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 lant outcomes to that of islets transplanted intraportal.
2                                              Intraportal 5-HT enhances NHGU but blunts nonhepatic glu
3 ive hemophilia B dogs that received a single intraportal administration of AAV2/8 vector have achieve
4 developed in the mice within 7 to 14 days of intraportal administration of adeno-associated virus (AA
5                            Both the oral and intraportal administration of butyrate led to a signific
6                                              Intraportal administration of LPS induced increased slee
7 andin synthesis inhibitor, and replicated by intraportal administration of prostaglandin E(2) or arac
8                            For a given dose, intraportal administration of rAAV CAGG-FIX resulted in
9 sequently, MHC-mismatched macaques underwent intraportal allogeneic islet transplantation and receive
10 betes with hypoglycemic unawareness received intraportal allogeneic islet transplants.
11 r subjects were randomized to peritransplant intraportal and systemic treatment with either LMW-DS or
12       We also evaluated AAV8 against AAV2 in intraportal and tail vein injections.
13 istics of these enzymes in rats subjected to intraportal bacterial endotoxin exposure (lipopolysaccha
14    Conversely, more intense proliferation of intraportal bile duct epithelia was seen with 2-AAF/AA t
15 = 4) by means of imaging-guided transhepatic intraportal catheterization.
16                                              Intraportal delivery of endothelial cell therapy or sali
17                            Three weeks after intraportal delivery of endothelial cells, the swine wer
18                                              Intraportal delivery of insulin in a constant versus pul
19 let bearing kidneys and were challenged with intraportal donor- or third party-type islets after beco
20 ous shunts was demonstrated by the use of an intraportal dye.
21 e used as recipients to study the effects of intraportal FH transplantation.
22  liver glycogen deposition was stimulated by intraportal fructose infusion in the presence of hypergl
23 upercompensated (SCGly) in two groups (using intraportal fructose infusion) but not in two others (Gl
24 se uptake using hyperglycemia and a low-dose intraportal fructose infusion.
25 = 4]), somatostatin, and glucose, as well as intraportal glucagon (basal).
26 n, fourfold basal intraportal insulin, basal intraportal glucagon, and peripheral glucose (to double
27       During the latter, somatostatin, basal intraportal glucagon, portal glucose (21.3 micromol x kg
28                                           An intraportal glucose infusion clamp was used in dogs to m
29  a hyperinsulinemic-hyperglycemic clamp with intraportal glucose infusion.
30 The efficiency of islet graft survival after intraportal implantation is compromised by host innate i
31                                   Subsequent intraportal infusion following extrahepatic transplants
32 digital subtraction angiography guidance for intraportal infusion of a 15%, 30%, or 50% by volume lip
33 lating hepatic glucose uptake, the effect of intraportal infusion of a small amount of fructose on ne
34                                 Furthermore, intraportal infusion of allogeneic islets results in the
35 ered diabetic with streptozocin and given an intraportal infusion of approximately 50 000 islet equiv
36                                 In contrast, intraportal infusion of collagen or fibronectin-like pol
37                  This study examines whether intraportal infusion of GSH can prevent HVOD in the mono
38                                              Intraportal infusion of GSH protects against monocrotali
39 an animal model of breast cancer metastasis, intraportal infusion of MDA-MB435 cells produced multipl
40                                        After intraportal infusion of porcine islets in primates, many
41                                              Intraportal infusion of small amounts of fructose marked
42 ne-partial hepatectomy rat model showed that intraportal infusion of the fibronectin-like polymer bef
43                       From 90 to 270 min, an intraportal infusion of the sGC inhibitor 1H-[1,2,4] oxa
44 mbined model was able to reproduce the known intraportal infusion profiles.
45 etion that were then compared with the known intraportal infusion rates.
46 ancreatic islets are exposed to blood during intraportal infusion, an innate immune response is trigg
47 cause the patients had contraindications for intraportal infusion, islets were infused in the BM.
48              Within the first 24 hours after intraportal infusion, we identified greater apoptosis (c
49 t in the liver for a minimum of 1 hour after intraportal infusion.
50                                    Equimolar intraportal infusions of insulin and C-peptide that are
51  sham-injected animals and in rats receiving intraportal infusions of microbeads.
52 fied human pancreatic islets over one or two intraportal infusions to achieve insulin independence an
53 Single tumor cells on the liver arising from intraportal injection also were detectable.
54 anted cells were retained in the liver after intraportal injection and in the liver and spleen after
55 in tumors 30 minutes after intraarterial and intraportal injection and was statistically significantl
56 30 vectors was tested after intramuscular or intraportal injection in female Sprague-Dawley rats with
57                                        After intraportal injection in patients, amyloid deposits <15
58 jection, the animals were challenged with an intraportal injection of 106 tumor cells, with subsequen
59            Here we demonstrate that a single intraportal injection of a recombinant adeno-associated
60                               Thus, a single intraportal injection of a recombinant adeno-associated
61                                   Similarly, intraportal injection of butyrate led to prompt and robu
62 iac allografts was induced by intravenous or intraportal injection of graft recipients with donor per
63                                        After intraportal injection of islets, inferior engraftment an
64                                              Intraportal injection of the graft recipients with donor
65                                        After intraportal injection of this vector, high-level, stable
66                                        After intraportal injection, LSEC were largely in the liver (6
67 nsplanted directly to the recipient liver by intraportal injection.
68 omized dogs that were given somatostatin and intraportal insulin (30 pmol x kg(-1) x min(-1)) for 360
69 ol x kg(-1) x min(-1)) was given, along with intraportal insulin (7.2 pmol x kg(-1) x min(-1)) and gl
70  During periods 1 and 2, somatostatin, basal intraportal insulin and glucagon, portal glucose (21.3 m
71                                              Intraportal insulin infusions (pulsatile, constant, or r
72 imental period, somatostatin, fourfold basal intraportal insulin, basal intraportal glucagon, and per
73 ion and autoimmune recurrence in therapeutic intraportal islet allografts.
74  end-differentiated beta-cell phenotype in 2 intraportal islet allotransplant recipients.
75 ificant prolongation of graft survival after intraportal islet allotransplantation (ITx) in rats: 7.2
76 utcomes for total-pancreatectomy followed by intraportal islet autotransplantation (TP-IAT) to treat
77                    Total pancreatectomy with intraportal islet autotransplantation (TPIAT) rather tha
78          Forty type 1 diabetes recipients of intraportal islet cell grafts under antithymocyte globul
79 ant advancement in the clinical relevance of intraportal islet cell transplantation for treatment of
80  In a clinical study, human subjects with an intraportal islet graft (n = 8) underwent two [(11)C]5-H
81 bility and problematic hypoglycemia received intraportal islet grafts under anti-thymocyte globulin-m
82                      Detection of amyloid in intraportal islet implants of type 1 diabetes patients h
83                    Using current techniques, intraportal islet infusion remains the gold standard for
84                Each patient had two to three intraportal islet infusions to obtain 10,000 islet equiv
85 BB rats were recipients of Wistar Furth (WF) intraportal islet or islets plus PLNC transplants with c
86  Onset and reversal of liver ischemia due to intraportal islet transplantation are detectable using T
87 liver NK cells significantly increased after intraportal islet transplantation as compared with the c
88 ficantly improves islet graft survival after intraportal islet transplantation by mitigation of coagu
89 essment of liver and islet engraftment after intraportal islet transplantation in a clinical setting.
90 or necrosis factor alpha) are released after intraportal islet transplantation lead to functional sup
91                                           In intraportal islet transplantation models using mouse and
92  clinical decision-making before entering an intraportal islet transplantation protocol.
93 observed in type 1 diabetic recipients after intraportal islet transplantation raises a question abou
94 ions occurring during radiologic or surgical intraportal islet transplantation significantly impair p
95                                        Thus, intraportal islet transplantation under conventional imm
96 betic recipients reached normoglycemia after intraportal islet transplantation when they were treated
97 ths and four subjects at 12 months following intraportal islet transplantation who had received compa
98            We report herein a consequence of intraportal islet transplantation, specifically the deve
99  to monitor viable islet mass after clinical intraportal islet transplantation.
100 detected in three patients immediately after intraportal islet transplantation.
101  play a role in early islet graft loss after intraportal islet transplantation.
102 8 nonuremic type 1 diabetic recipients of an intraportal islet-cell graft under maintenance immunosup
103 evaluates patients receiving extrahepatic or intraportal ITx between 1999 and 2018.
104           However, clinical comparisons with intraportal ITx outcomes remain limited.
105 .6, P < 0.001) compared with those receiving intraportal ITx.
106  to monitor viable transplanted islets after intraportal ITx.
107 ompatibility complex-mismatched, allogeneic, intraportal (liver) islet transplantation model.
108 a first-pass effect, in a large animal (pig) intraportal marginal mass islet autotransplant model.
109 ge of hepatic VEGF using either MMP-9 ASO or intraportal MMP inhibitor in 5-week and 10-week HFHF rat
110                          Rescue therapy with intraportal MMP inhibitor, given after ischemia, in the
111 ce that received as few as 50 islets, either intraportal or in the epididymal fat pad, displayed simi
112 may originate from cells derived from either intraportal or periportal ductules.
113 lowed by proliferation of cholangiocytes and intraportal oval cells.
114                                       During intraportal pancreatic islet transplantation (PITx), ear
115                                              Intraportal pancreatic islet transplantation could poten
116                                              Intraportal phlorizin, a competitive inhibitor of glucos
117              Eight diabetic monkeys received intraportal porcine islet transplantation.
118                        Ten monkeys underwent intraportal porcine islet transplantation.
119  a pancreatic clamp with glucose unclamped + intraportal propranolol and phentolamine hepatic alpha-
120 argeted to the liver more effectively by the intraportal rather than the intrasplenic route.
121                                 However, the intraportal route of transplantation is associated with
122 mmunodeficiency mice through intrasplenic or intraportal routes.
123             The -sGC/+NO group also received intraportal SIN-1 (NO donor) to elevate hepatic NO from
124 t, and offers a potential alternative to the intraportal site for islet and future stem cell therapie
125                         In rat recipients of intraportal syngeneic transplants, evidence that NO is p
126 er-directed endothelial cell therapy with an intraportal technique for the treatment of cirrhosis in
127                                              Intraportal thrombolytic infusion, angioplasty, and sten
128 nt outcomes compared with patients receiving intraportal transplant alone.
129 eatic islets are destroyed immediately after intraportal transplantation by an instant blood-mediated
130  reduced loss of functional islet mass after intraportal transplantation in diabetic mice.
131 nces of IKKbeta knockdown in vitro and after intraportal transplantation in mice.
132 mation and preserves functional islets after intraportal transplantation in mice.
133 vitro by static incubation and in vivo after intraportal transplantation in syngeneic streptozotocin-
134                                              Intraportal transplantation is associated with procedura
135 tained function in a marginal mass syngeneic intraportal transplantation model.
136 slets as control in a syngeneic minimal mass intraportal transplantation model.
137 (2)), or normoxic (21%O(2)) conditions after intraportal transplantation of 350, 500, 700, or 1,000 s
138                                              Intraportal transplantation of a marginal mass (50 islet
139 more than 100 d in cynomolgus macaques after intraportal transplantation of cultured islets from gene
140 cific bone marrow is performed together with intraportal transplantation of islets of Langerhans, GVH
141 glycemia was not restored in rats treated by intraportal transplantation of islets.
142  the time needed to restore euglycemia after intraportal transplantation of syngeneic islets in diabe
143        In a syngeneic marginal mass model of intraportal transplantation, SA-CD47-engineered islets s
144 nses that cause substantial islet loss after intraportal transplantation.
145 e agents with improved engraftment following intraportal transplantation.
146                                 We performed intraportal transplants of wild-type adult porcine islet
147 ntrast to the mice that received AAV-hFIX by intraportal vein (IPV) administration.
148                                        After intraportal vein injection of these vectors in hemophili
149 n the basis of studies that investigated the intraportal versus systemic insulin infusion and transen
150 "), as well as type I cells, are seen in the intraportal zone of the liver within 1 to 2 days after c

 
Page Top